Cardiovascular risk assessment with regadenoson SPECT MPI in patients with end-stage renal disease is safe, effective, and well tolerated: Does it matter?

被引：0
|
作者：
Erica O. Miller
Ronald G. Schwartz
机构：
[1] University of Rochester Medical Center,Cardiology Division, Department of Medicine
[2] University of Rochester Medical Center,Nuclear Medicine Division, Department of Imaging Sciences
来源：
Journal of Nuclear Cardiology | 2017年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：119 / 121
页数：2
相关论文
共 50 条
  • [21] The challenge of cardiovascular risk factors in end-stage renal disease
    Covic, A
    Gusbeth-Tatomir, P
    Goldsmith, DJA
    JOURNAL OF NEPHROLOGY, 2003, 16 (04) : 476 - 486
  • [22] Emerging cardiovascular risk factors in end-stage renal disease
    Yaqoob, MM
    JOURNAL OF NEPHROLOGY, 2002, 15 (02) : 205 - 208
  • [23] Novel cardiovascular risk factors in end-stage renal disease
    Zoccali, C
    Mallamaci, F
    Tripepi, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (01): : S77 - S80
  • [24] The safety and tolerability of regadenoson in patients with end-stage renal disease: The first prospective evaluation
    Rami Doukky
    Maria Octavia Rangel
    Marwan Wassouf
    Rizcallah Dick
    Ammar Alqaid
    Raysa Morales Demori
    Journal of Nuclear Cardiology, 2013, 20 : 205 - 213
  • [25] The safety and tolerability of regadenoson in patients with end-stage renal disease: The first prospective evaluation
    Doukky, Rami
    Rangel, Maria Octavia
    Wassouf, Marwan
    Dick, Rizcallah
    Alqaid, Ammar
    Demori, Raysa Morales
    JOURNAL OF NUCLEAR CARDIOLOGY, 2013, 20 (02) : 205 - 213
  • [26] THE SAFETY AND TOLERABILITY OF REGADENOSON IN PATIENTS WITH END-STAGE RENAL DISEASE: THE FIRST PROSPECTIVE EVALUATION
    Rangel, Maria Octavia
    Wassouf, Marwan
    Dick, Rizcallah
    Morales-Demori, Raysa C.
    Pant, Rojina
    Margeta, Bosko
    Doukky, Rami
    Stroger, John H., Jr.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1313 - E1313
  • [27] Familiality of Cardiovascular Mortality in End-Stage Renal Disease Patients
    Naiman, Natalie
    Cheung, Alfred K.
    Goldfarb-Rumyantzev, Alexander S.
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (03) : 237 - 243
  • [28] Urotensin and cardiovascular risk among patients with end-stage renal disease: Fact or fiction?
    Boos, CJ
    Lip, GYH
    AMERICAN JOURNAL OF HYPERTENSION, 2006, 19 (05) : 511 - 512
  • [29] 3D Echocardiography - A Useful Method for Cardiovascular Risk Assessment in End-Stage Renal Disease Patients
    Kovarova, Magdalena
    Zilinska, Zuzana
    Pales, Jan
    Kuzmova, Zuzana
    Gazova, Andrea
    Smaha, Juraj
    Kuzma, Martin
    Jackuliak, Peter
    Stvrtinova, Viera
    Kyselovic, Jan
    Payer, Juraj
    PHYSIOLOGICAL RESEARCH, 2021, 70 : S109 - S120
  • [30] Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients
    Fung, F
    Sherrard, DJ
    Gillen, DL
    Wong, C
    Kestenbaum, B
    Seliger, S
    Ball, A
    Stehman-Breen, C
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (02) : 307 - 314
12345